GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ANG Lifesciences India Ltd (BOM:540694) » Definitions » Net Income (Continuing Operations)

ANG Lifesciences India (BOM:540694) Net Income (Continuing Operations) : ₹-140 Mil (TTM As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is ANG Lifesciences India Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. ANG Lifesciences India's Net Income (Continuing Operations) for the three months ended in Dec. 2024 was ₹-52 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-140 Mil.


ANG Lifesciences India Net Income (Continuing Operations) Historical Data

The historical data trend for ANG Lifesciences India's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANG Lifesciences India Net Income (Continuing Operations) Chart

ANG Lifesciences India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.96 70.28 403.17 -2.62 -101.43

ANG Lifesciences India Quarterly Data
Sep19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -59.31 -36.47 -30.73 -20.89 -51.91

ANG Lifesciences India Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-140 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ANG Lifesciences India  (BOM:540694) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


ANG Lifesciences India Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of ANG Lifesciences India's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


ANG Lifesciences India Business Description

Traded in Other Exchanges
N/A
Address
Ranjit Avenue, B-Block, Darbara Complex, SCO 113, First Floor, District Shopping Complex, Amritsar, PB, IND, 143001
ANG Lifesciences India Ltd is an India-based engaged in the manufacturing of finished pharmaceutical formulations in the form of dry powder for injections. The Group has two reportable segments: Pharmaceuticals which include Manufacturing of pharmaceutical products, and Packaging and printing which include Prinitng and packaging. Key revenue is generated from Pharmaceuticals.

ANG Lifesciences India Headlines

No Headlines